NEW YORK (GenomeWeb) – The US Food and Drug Administration yesterday granted emergency use authorization to Thermo Fisher Scientific's TaqPath Zika Virus Kit.

The kit is authorized to be conducted by CLIA-certified labs in the US only for the qualitative detection of RNA from Zika virus and diagnosis of Zika virus infection in human serum and urine collected alongside a patient-matched serum specimen. Individuals receiving the test must meet US Centers for Disease Control and Prevention Zika virus clinical and/or epidemiological criteria.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.